Navigation Links
FDA Expands Use of Prevnar 13 Vaccine for People Ages 50 and Older
Date:12/30/2011

SILVER SPRING, Md., Dec. 30, 2011 /PRNewswire-USNewswire/ -- Prevnar 13, a pneumococcal 13-valent conjugate vaccine, was approved today by the U.S. Food and Drug Administration for people ages 50 years and older to prevent pneumonia and invasive disease caused by the bacterium, Streptococcus pneumoniae.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

Pneumococcal pneumonia, caused when the bacterium Streptococcus pneumoniae infects the lungs, is the most common disease caused by this bacterium in adults. When the bacterium invades parts of the body that are normally free from germs, such as the blood or spinal fluid, the disease is considered "invasive."

"According to recent information for the United States, it is estimated that approximately 300,000 adults 50 years of age and older are hospitalized yearly because of pneumococcal pneumonia," said Karen Midthun, M.D., director of FDA's Center for Biologics Evaluation and Research. "Pneumococcal disease is a substantial cause of illness and death. Today's approval provides an additional vaccine for preventing pneumococcal pneumonia and invasive disease in this age group."  

The new use for Prevnar 13 was approved under the agency's accelerated approval pathway, which allows for earlier approval of treatments for serious and life-threatening illnesses. The pathway allows for the demonstration of effectiveness of a vaccine using an immune marker that is reasonably likely to predict clinical benefit.

In randomized, multi-center studies in the United States and Europe, people 50 and older received either Prevnar 13 or Pneumovax 23, a licensed pneumococcal vaccine also approved for use in this age group. The studies showed that for the 12 common serotypes, Prevnar 13 induced antibody levels that were either comparable to or higher than the levels induced by Pneumovax 23.

The safety of Prevnar 13 was evaluated in about 6,000 p
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Inspiration Biopharmaceuticals Expands Leadership Team with Four New Hires
2. FDA Expands Use of HIV Drug Isentress to Children and Adolescents
3. Radient Pharmaceuticals Corporation Expands Distribution of Onko-Sure® in Asia; Receives Payment on First Order of 60 Kits
4. Saladax Biomedical, Inc. Expands Distribution of My5-FU in Europe
5. Lilly for Better Health™ Expands Website to Include Spanish Health Information and Interactive Tools
6. Sony Expands Radiology Product Offerings with Full Line of Diagnostic Displays
7. Leading Indian CRO Max Neeman International Expands in Response to Positive Biosimilars Market in India
8. Panasonic Expands on Hearing Instrument Lineup
9. Gaylord Sleep Medicine Expands Sleep Apnea Management Program
10. Abbott Expands Agreement with GSK to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen
11. Free Statewide Rx Assistance Program Expands
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , July 31, 2014  According to data released ... the 2015 average monthly Medicare Part D premium is ... lower than was originally projected, the Pharmaceutical Care Management ... program continues to be a bright spot in American ... in each region and using cutting edge, cost-saving tools ...
(Date:7/31/2014)... 31, 2014  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... Singh , Chief Business Officer and Executive Vice President. Mr. ... July 30. "Sorrento is deeply saddened and shocked ... immediate thoughts go to Amar,s family and friends," said ... Mr. Singh joined Sorrento in January 2014 ...
(Date:7/31/2014)... 31, 2014 STAAR Surgical Company (NASDAQ: ... of implantable lenses and delivery systems for the eye ... 4, 2014 of $20.0 million, a 10% increase over ... On a constant currency basis, revenues grew 11% during ... quarter of 2013.  The effect of foreign currency exchange ...
Breaking Medicine Technology:Sorrento Announces the Unexpected Death of its Chief Business Officer 2STAAR Surgical Reports 10% Second Quarter Revenue Growth 2STAAR Surgical Reports 10% Second Quarter Revenue Growth 3STAAR Surgical Reports 10% Second Quarter Revenue Growth 4STAAR Surgical Reports 10% Second Quarter Revenue Growth 5STAAR Surgical Reports 10% Second Quarter Revenue Growth 6STAAR Surgical Reports 10% Second Quarter Revenue Growth 7STAAR Surgical Reports 10% Second Quarter Revenue Growth 8STAAR Surgical Reports 10% Second Quarter Revenue Growth 9STAAR Surgical Reports 10% Second Quarter Revenue Growth 10STAAR Surgical Reports 10% Second Quarter Revenue Growth 11STAAR Surgical Reports 10% Second Quarter Revenue Growth 12STAAR Surgical Reports 10% Second Quarter Revenue Growth 13STAAR Surgical Reports 10% Second Quarter Revenue Growth 14STAAR Surgical Reports 10% Second Quarter Revenue Growth 15STAAR Surgical Reports 10% Second Quarter Revenue Growth 16STAAR Surgical Reports 10% Second Quarter Revenue Growth 17STAAR Surgical Reports 10% Second Quarter Revenue Growth 18STAAR Surgical Reports 10% Second Quarter Revenue Growth 19STAAR Surgical Reports 10% Second Quarter Revenue Growth 20STAAR Surgical Reports 10% Second Quarter Revenue Growth 21STAAR Surgical Reports 10% Second Quarter Revenue Growth 22STAAR Surgical Reports 10% Second Quarter Revenue Growth 23STAAR Surgical Reports 10% Second Quarter Revenue Growth 24STAAR Surgical Reports 10% Second Quarter Revenue Growth 25STAAR Surgical Reports 10% Second Quarter Revenue Growth 26STAAR Surgical Reports 10% Second Quarter Revenue Growth 27STAAR Surgical Reports 10% Second Quarter Revenue Growth 28STAAR Surgical Reports 10% Second Quarter Revenue Growth 29STAAR Surgical Reports 10% Second Quarter Revenue Growth 30STAAR Surgical Reports 10% Second Quarter Revenue Growth 31
... Oct. 14 Cephalon, Inc. (Nasdaq: CEPH ... Strategy (REMS) for its antiepileptic medication GABITRIL(R) (tiagabine hydrochloride) ... Administration (FDA).  The GABITRIL REMS consists of a Medication ... with the use of GABITRIL.  The implementation of the ...
... SMA ), a leading independent provider of products ... announced today that it will release third quarter 2010 financial ... market opens on Thursday, November 4, 2010. Symmetry Medical will ... Thursday, November 4, 2010. A live Web ...
Cached Medicine Technology:Cephalon Announces FDA Approval of a Risk Evaluation and Mitigation Strategy for GABITRIL 2Cephalon Announces FDA Approval of a Risk Evaluation and Mitigation Strategy for GABITRIL 3Cephalon Announces FDA Approval of a Risk Evaluation and Mitigation Strategy for GABITRIL 4Symmetry Medical to Report Third Quarter 2010 Financial Results on November 4, 2010 2
(Date:7/31/2014)... The 2013 edition of the ... listings, appellate decisions, litigation and settlement trends, trials, ... with California's Proposition 65. , The Handbook is ... history and trends impacting California's Proposition 65. ... the series which adds approximately 200 pages devoted ...
(Date:7/31/2014)... 31, 2014 Serious buyer, Andrew Hawley, ... Test concert posters. Owsley Bear Stanley, the King of ... Grateful Dead. According to Hawley, “The Grateful Dead and ... test parties in San Francisco and Los Angeles in ... three different colors of paper. They were a goldenrod ...
(Date:7/31/2014)... 1, 2014) Women over the age of 65 ... for obesity, greater struggles against poverty and higher rates ... in the August issue of Annals of Allergy, ... American College of Allergy, Asthma and Immunology (ACAAI), outlines ... and offers practical solutions to improve their care. ...
(Date:7/31/2014)... ARLINGTON HEIGHTS, Ill. (August 1, 2014) If you have ... a "stoplight system" to help you recognize and respond to ... more attention. If you,re in the green zone, you,re doing ... needed, and red means you require urgent care. New guidelines ... of the yellow zone, back into green and away from ...
(Date:7/31/2014)... who recently used birth control pills containing high-dose estrogen ... for breast cancer, whereas women using some other formulations ... Research , a journal of the American Association for ... contemporary oral contraceptives [birth control pills] in the past ... relative to never or former oral contraceptive use, and ...
Breaking Medicine News(10 mins):Health News:Save 25% on the Proposition 65 Handbook - 2013 Edition Through August 31 2Health News:Female baby boomers with asthma? You may need help 2Health News:Female baby boomers with asthma? You may need help 3Health News:Recent use of some birth control pills may increase breast cancer risk 2
... , , , NEWPORT ... NHP ) announced today that the Company will release its 2009 second ... on the New York Stock Exchange. The Company will host a ... Pacific time (11:30 a.m. Eastern time) to discuss these results. , ...
... , American Association for Homecare ... Harmful Rules that Cause Confusion, Service Disruption, and Reduced Access to ... , ARLINGTON, Va., July 16 The ... Meek (D-Fla.) for introducing the Medicare Home Oxygen Therapy Act of ...
... , , , ... OMCL ), a leading provider of system solutions to acute healthcare facilities, ... Quarter 2009 financial results. , , ... call and webcast, When: July 23, 2009, 1:30 ...
... SAN FRANCISCO, July 16 Litigation and insurance coverage claims involving ... is the focus of a half-day seminar 7:30 am to 12:30 ... at the University of California San Francisco. The event will ... conference producer, HB Litigation Conferences LLC, has selected the first of ...
... , WASHINGTON, July 16 Partnership ... the House version of a health care reform bill to raise ... to a special fund to finance prevention and wellness initiatives. , ... an important tool in reducing the public health toll of alcohol ...
... lives, government should enact new interstate laws, researchers say ... and injuries on America,s interstates have increased since the ... a new study finds, and some believe it,s ... attributed 12,545 deaths and 36,582 injuries in fatal crashes ...
Cached Medicine News:Health News:NHP Announces Second Quarter Earnings Release Date and Webcast/Conference Call 2Health News:Congressmen Mike Ross and Kendrick Meek Introduce Bill to Protect Medicare Patients Who Require Medical Oxygen Therapy at Home 2Health News:Congressmen Mike Ross and Kendrick Meek Introduce Bill to Protect Medicare Patients Who Require Medical Oxygen Therapy at Home 3Health News:Omnicell to Release Second Quarter 2009 Earnings Results on July 23 2Health News:Chinese Drywall Litigation & Insurance Conference July 28 in San Francisco 2Health News:Raise Federal Alcohol Tax to Finance Prevention Trust Fund, Partnership Urges House Chairmen 2Health News:Deaths, Injuries Increase With Higher Speed Limits 2Health News:Deaths, Injuries Increase With Higher Speed Limits 3
Ties improve torso fit and transfer weight to waist and hips. Ties are 1"W cotton woven for flexibility and sewn at an angle across the full width of the two back sections for durability....
Ties improve torso fit and transfer weight to waist and hips. Ties are 1"W cotton woven for flexibility and sewn at an angle across the full width of the two back sections for durability....
Hip-hugging design transfers weight from shoulders to the hips. Crisscross shoulder design provides snug and comfortable upper torso fit while preventing apron from slipping off shoulders....
Freedom of movement - plus full circle, maximum radiation protection. No other full circle radiation protection design approaches the level of comfort of the VestSkirt, which divides weight between t...
Medicine Products: